PLATT DAVID 4
4 · BIOXYTRAN, INC · Filed Mar 27, 2024
Insider Transaction Report
Form 4
BIOXYTRAN, INCBIXT
PLATT DAVID
DirectorCEO10% Owner
Transactions
- Award
common
2024-03-27$0.10/sh+439,595$45,718→ 20,133,018 total(indirect: by NDPD Pharma, Inc.)
Footnotes (1)
- [F1]The total holdings in BIXT by NDPD Pharma, Inc., partly owned by officers of BIXT, are consolidated under indirect ownership in Davis Platt's filing.